Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN111362973A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111362973A details a cost-effective, one-step copper-catalyzed route to 1,2-benzothiazine derivatives, offering significant advantages for pharmaceutical intermediate manufacturing.